Episode Details

In his weekly clinical update, Daniel Griffin and Vincent Racaniello reviewed the latest developments surrounding the hantavirus outbreak, including new interim guidance from the Centers for Disease Control and Prevention for the management of infectious cases, whether the CDC may be downplaying the significance of the outbreak because of public backlash following the COVID-19 pandemic, before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, benefit of maternal vaccination against RSV for infants, efficacy and safety of a mRNA influenza vaccine how to access and pay for Paxlovid, where to go for answers about long COVID-19, multisystem inflammatory syndrome in children and contacting your federal government representative to stop the assault on science and biomedical research.

Become a patron of TWiV!

• Interim Guidance for Public Health Assessment and Management of People with Potential Exposure to Andes Virus Outbreak (CDC)
• Hantavirus in humans: a review of clinical aspects and management (LANCET: Infectious Diseases)
• "Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina (NEJM)
• Person-to-Person Transmission of Andes Virus in Hantavirus Pulmonary Syndrome, Argentina, 2014 (CDC: Emerging Infectious Diseases)
• Hantavirus on board with Prof. Vincent Racaniello (microbeTV)
• Transcript – Updateon CDC's Hantavirus Response 5/13/2026 (CDC)
• CDC Is Walking a Tightrope With Its Response to Hantavirus (Wall Street Journal)
• What Happened on the Hantavirus Cruise, According to a Doctor On Board (The Atlantic)
• Andes hantavirus outbreak on a cruise ship – an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment (CMI: Clinical Microbiology and Infection)

• Listen Now